New Zealand markets closed

Ocular Therapeutix, Inc. (OCUL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.8000-0.1000 (-3.45%)
At close: 04:00PM EST
2.9400 +0.14 (+5.00%)
After hours: 05:04PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
49,727
43,522
17,403
4,227
1,990
Cost of revenue
4,636
4,406
2,083
2,325
465
Gross profit
45,091
39,116
15,320
1,902
1,525
Operating expenses
Research development
52,497
50,083
28,694
41,091
36,915
Selling general and administrative
69,936
67,070
49,473
46,613
23,728
Total operating expenses
122,433
117,153
78,167
87,704
60,643
Operating income or loss
-77,342
-78,037
-62,847
-85,802
-59,118
Interest expense
6,855
6,671
6,768
6,101
1,739
Total other income/expenses net
24,470
78,122
-86,189
4,302
-
Income before tax
-59,346
-6,553
-155,636
-86,372
-59,978
Income from continuing operations
-59,346
-6,553
-155,636
-86,372
-59,978
Net income
-59,346
-6,553
-155,636
-86,372
-59,978
Net income available to common shareholders
-59,346
-6,553
-155,636
-86,372
-59,978
Basic EPS
-
-0.09
-2.56
-1.91
-1.57
Diluted EPS
-
-0.98
-2.56
-1.91
-1.57
Basic average shares
-
76,393
60,752
45,273
38,115
Diluted average shares
-
82,162
60,752
45,273
38,115
EBITDA
-
2,539
-146,095
-77,741
-55,953